F2G Biotech GmbH
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Olorofim Aspergillus Infection Study (NCT05101187) | F2G Biotech GmbH | 2022-03-31 |
| A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment (NCT05200286) | F2G Biotech GmbH | 2022-02-10 |
| A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment (NCT04752540) | F2G Biotech GmbH | 2021-07-02 |
Track F2G Biotech GmbH automatically
Every clearance here is in the API, with alerts when new ones post.